Isoflavone phytoestrogen — binds ER-β preferentially (10–20× over ER-α). Gut microbial conversion by Slackia isoflavoniconvertens / Adlercreutzia equolifaciens yields S-equol, the more active metabolite — only ~25–50% of adults are 'equol producers' depending on gut composition, which explains much of the clinical heterogeneity in soy studies.
Half-Life & Elimination Curve (PO: 7.8h)
Plasma (PO)t½ Decay (7.8h)
0×t½0h100%(0.463 mg/L)
1×t½7.8h50%(0.231 mg/L)
2×t½15.6h25%(0.116 mg/L)
3×t½23.4h12.5%(57.9 µg/L)
4×t½31.2h6.3%(28.9 µg/L)
5×t½39h3.1%(14.5 µg/L)
Elimination t½7.8h (PO)
Rate Constant (ke)0.0889 h⁻¹
Time to Peak (Tmax)3.09h
Est. Peak (Cmax)0.463 mg/L
Clearance (CL)3.11 L/h
97% Washout (5×t½)39h
Dosing Guidelines
Oral (PO): Typical 53.3 mg (Range: 40–80 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 40% · Volume of Distribution (Vd): 35 L · Absorption (ka): 0.8 h⁻¹ (t½ka ≈ 52m) [PMID 12672914]